← Browse by Condition
Medical Condition

lung transplantation

Total Trials
4
Recruiting Now
4
Trial Phases
Various

ClinicalMetric tracks all active clinical trials for lung transplantation sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — lung transplantation Clinical Trials

How many clinical trials are currently recruiting for lung transplantation?
ClinicalMetric currently tracks 4 actively recruiting clinical trials for lung transplantation, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 4. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for lung transplantation?
lung transplantation research spans multiple clinical trial phases. Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a lung transplantation clinical trial?
Eligibility criteria for lung transplantation trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Top Sponsors
University of Alberta 1 trial
University of Pennsylvania 1 trial
NYU Langone Health 1 trial
University of Padova 1 trial

Recruiting Clinical Trials

NCT05837663
Recruiting

Trifecta-Lung cfDNA-MMDx Study

Enrollment
600 pts
Location
United States, Austr...
Sponsor
University of Alberta
View Trial →
NCT00552357
Recruiting

Risk Factors That Increase the Chance of Developing Primary Graft Dysfunction After Lung Transplantation

Enrollment
1,150 pts
Location
United States
Sponsor
University of Pennsylvania
View Trial →
NCT06327945
Recruiting

Transplanting Lungs From Uncontrolled Donation After Circulatory Death

Enrollment
24 pts
Location
United States
Sponsor
NYU Langone Health
View Trial →
NCT05689476
Recruiting

Electrical Activity of the Diaphragm and Respiratory Mechanics During NAVA

Enrollment
40 pts
Location
Italy
Sponsor
University of Padova
View Trial →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology